Skip to main content

Table 3 Summary of adverse events

From: A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status

Adverse Events Total FDI Placebo
Infections 5 Infections consisting of one urinary tract infection (UTI); 1 lower respiratory tract infection (LRTI), 1 flu and one exacerbation of chronic obstructive pulmonary disease (eCOPD) and one shingles flare 1 flu
1 UTI,
1 infective
1 eCOPD
1 LRTI
1 shingles
Cardiovascular events Angina × 2 0 2
Shortness of breath 2 0 2
Other Hypoglycaemia
Had intravenous fluid for elective CT scan
? lung Cancer
Gout
Depression
Per Rectal bleeding
Acute Kidney Injury episode
Cough
Poor Blood Pressure control
0
0
0
1
1
0
0
1
1
2
1
0
1
0
0
1
1
0
0
0
  19
in 13 patients
9
in 6 patients
10
in 7 patients